Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma

Fig. 3

Kaplan-Meier survival curves of ESCC patients. a The 3-year OS rate of 80 ESCC patients was 52.23%. b The 3-year OS rates in ESCC patients with IgG < 138.23 EU (n = 61) and IgG > 138.23 EU (n = 19) were 70.145% and 32.68%, respectively, with a significant difference (P = 0.028). c The 3-year OS rates in ESCC patients with IgA < 56.56 EU (n = 64) and IgG > 56.56 EU (n = 16) were 60.82% and 18.83%, respectively, with a significant difference (P = 0.006). d The 3-year OS rates in ESCC patients with IgG < 138.23 EU or IgA < 56.56 (n = 50) and IgG > 138.23 EU or IgA > 56.56 (n = 30) were 76.38% and 34.04%, respectively, with a significant difference (P = 0.007)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us